These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23148656)

  • 21. QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.
    Zhang L; Zhu H; Oprea TI; Golbraikh A; Tropsha A
    Pharm Res; 2008 Aug; 25(8):1902-14. PubMed ID: 18553217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus QSAR modeling of toxicity of pharmaceuticals to different aquatic organisms: Ranking and prioritization of the DrugBank database compounds.
    Khan K; Benfenati E; Roy K
    Ecotoxicol Environ Saf; 2019 Jan; 168():287-297. PubMed ID: 30390527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixtures-Inclusive
    Sedykh A; Choksi NY; Allen DG; Casey WM; Shah R; Kleinstreuer NC
    Chem Res Toxicol; 2022 Jun; 35(6):992-1000. PubMed ID: 35549170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions.
    Sedykh A; Fourches D; Duan J; Hucke O; Garneau M; Zhu H; Bonneau P; Tropsha A
    Pharm Res; 2013 Apr; 30(4):996-1007. PubMed ID: 23269503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches.
    Kim MT; Sedykh A; Chakravarti SK; Saiakhov RD; Zhu H
    Pharm Res; 2014 Apr; 31(4):1002-14. PubMed ID: 24306326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices.
    Contrera JF; Matthews EJ; Daniel Benz R
    Regul Toxicol Pharmacol; 2003 Dec; 38(3):243-59. PubMed ID: 14623477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR Modeling of ToxCast Assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis.
    Gadaleta D; Manganelli S; Roncaglioni A; Toma C; Benfenati E; Mombelli E
    J Chem Inf Model; 2018 Aug; 58(8):1501-1517. PubMed ID: 29949360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combinatorial QSAR modeling of P-glycoprotein substrates.
    de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
    J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards global QSAR model building for acute toxicity: Munro database case study.
    Chavan S; Nicholls IA; Karlsson BC; Rosengren AM; Ballabio D; Consonni V; Todeschini R
    Int J Mol Sci; 2014 Oct; 15(10):18162-74. PubMed ID: 25302621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. QSAR modelling of inhalation toxicity of diverse volatile organic molecules using no observed adverse effect concentration (NOAEC) as the endpoint.
    Nath A; De P; Roy K
    Chemosphere; 2022 Jan; 287(Pt 1):131954. PubMed ID: 34478968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating sensory irritation potency of volatile organic chemicals using QSARs based on decision tree methods for regulatory purpose.
    Gupta S; Basant N; Singh KP
    Ecotoxicology; 2015 May; 24(4):873-86. PubMed ID: 25707485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a QSAR model for acute toxicity.
    Pavan M; Netzeva TI; Worth AP
    SAR QSAR Environ Res; 2006 Apr; 17(2):147-71. PubMed ID: 16644555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. General baseline toxicity QSAR for nonpolar, polar and ionisable chemicals and their mixtures in the bioluminescence inhibition assay with Aliivibrio fischeri.
    Escher BI; Baumer A; Bittermann K; Henneberger L; König M; Kühnert C; Klüver N
    Environ Sci Process Impacts; 2017 Mar; 19(3):414-428. PubMed ID: 28197603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STopTox: An
    Borba JVB; Alves VM; Braga RC; Korn DR; Overdahl K; Silva AC; Hall SUS; Overdahl E; Kleinstreuer N; Strickland J; Allen D; Andrade CH; Muratov EN; Tropsha A
    Environ Health Perspect; 2022 Feb; 130(2):27012. PubMed ID: 35192406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple stochastic fingerprints towards mathematical modeling in biology and medicine. 3. Ocular irritability classification model.
    Cruz-Monteagudo M; González-Díaz H; Borges F; González-Díaz Y
    Bull Math Biol; 2006 Oct; 68(7):1555-72. PubMed ID: 16865609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting drug-induced hepatotoxicity using QSAR and toxicogenomics approaches.
    Low Y; Uehara T; Minowa Y; Yamada H; Ohno Y; Urushidani T; Sedykh A; Muratov E; Kuz'min V; Fourches D; Zhu H; Rusyn I; Tropsha A
    Chem Res Toxicol; 2011 Aug; 24(8):1251-62. PubMed ID: 21699217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated QSAR Models to Predict Acute Oral Systemic Toxicity.
    Ballabio D; Grisoni F; Consonni V; Todeschini R
    Mol Inform; 2019 Aug; 38(8-9):e1800124. PubMed ID: 30549437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Modeling of Estrogen Receptor Binding Agents Using Advanced Cheminformatics Tools and Massive Public Data.
    Ribay K; Kim MT; Wang W; Pinolini D; Zhu H
    Front Environ Sci; 2016 Mar; 4():. PubMed ID: 27642585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-toxicity relationships of organic chemicals against Pseudokirchneriella subcapitata.
    Yu X
    Aquat Toxicol; 2020 Jul; 224():105496. PubMed ID: 32408003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative structure-property relationships modeling of skin irritation.
    Golla S; Madihally S; Robinson RL; Gasem KA
    Toxicol In Vitro; 2009 Feb; 23(1):176-84. PubMed ID: 19027061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.